Roles and therapeutic opportunities of ω-3 long-chain polyunsaturated fatty acids in lung cancer
Jiang Luo,
Shu Peng,
Ziyu Jiang,
Qingwei Wang,
Mini Zhang,
Yuxin Zeng,
Yu Yuan,
Min Xia,
Zixi Hong,
Yufei Yan,
Yushuang Tan,
Jiawen Tang,
Conghua Xie,
Yan Gong
Affiliations
Jiang Luo
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China; Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China
Shu Peng
Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Ziyu Jiang
Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China
Qingwei Wang
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Mini Zhang
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Yuxin Zeng
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Yu Yuan
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Min Xia
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Zixi Hong
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Yufei Yan
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Yushuang Tan
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
Jiawen Tang
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China; Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China
Conghua Xie
Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Key Laboratory of Tumor Biological Behavior, Zhongnan Hospital of Wuhan University, Wuhan, China; Corresponding author
Yan Gong
Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Key Laboratory of Tumor Biological Behavior, Zhongnan Hospital of Wuhan University, Wuhan, China; Corresponding author
Summary: Over the past decades, researchers have continuously investigated the potential functions of long-chain polyunsaturated fatty acids (LCPUFAs) in cancers, including lung cancer. The ω-3 LCPUFAs, primarily consisting of eicosapentaenoic acid and docosahexaenoic acid, were found to modify inflammatory tumor microenvironment, induce cancer cell apoptosis and autophagy, and suppress tumor development when administered alone or with other therapeutical strategies. Although the precise anti-tumor mechanism has not been elucidated yet, ω-3 LCPUFAs are often used in the nutritional treatment of patients with cancer due to their ability to significantly improve patient’s nutritional status, increase the sensitivity of tumor cells to treatments, and alleviate cancer-related complications. Here we present the key roles of ω-3 LCPUFAs as dietary supplementations in lung cancer, comprehensively review the recent progress on the underlying mechanisms of cancer cell regulation by ω-3 LCPUFAs, and introduce the application of ω-3 LCPUFAs in the clinical management of lung cancer and its malignant complications.